SEOUL, South Korea--(BUSINESS WIRE)--EverEx, a musculoskeletal digital healthcare startup in South Korea, has been honored with the world-renowned design prize, the iF Design Award. The award for 'MORA,' in the service design category for healthcare, highlights the company's significant achievements..

韩国首尔--（商业新闻短讯）--EverEx是韩国一家肌肉骨骼数字医疗保健初创公司，获得了世界著名的设计奖，即iF设计奖。医疗保健服务设计类“莫拉”奖突显了该公司取得的重大成就。。

Organized annually by the Hannover-based iF International Forum Design GmbH, the iF Design Award is highly revered in the design community. With its outstanding functionality, user interface, and experience, “MORA” captured the attention of a 132-member jury of international experts, triumphing amidst a competitive field of nearly 11,000 entries from 72 countries.

每年由总部位于汉诺威的iF国际论坛设计有限公司举办，iF设计奖在设计界受到高度尊重。凭借其出色的功能、用户界面和体验，“MORA”吸引了132名国际专家组成的评审团的注意力，在来自72个国家近11000名参赛者的竞争中获胜。

This accolade, following closely after the CES 2024 Innovation Award win in digital healthcare, further cements EverEx's position as a leader in musculoskeletal rehabilitation..

继CES 2024数字医疗创新奖获得后，这一荣誉进一步巩固了EverEx在肌肉骨骼康复领域的领先地位。。

Dr. Chan Yoon, CEO of EverEx, commented, “Winning the iF Design Award underscores our commitment to enhancing the efficiency and accessibility of rehabilitation practices through digital innovation. We remain dedicated to the continual improvement of our products, valuing the feedback from our users to adapt to the evolving demands of digital healthcare environments.”.

EverEx首席执行官Chan Yoon博士评论道：“获得iF设计奖突显了我们致力于通过数字创新提高康复实践的效率和可访问性。我们仍然致力于不断改进产品，重视用户的反馈，以适应数字医疗环境不断变化的需求。”。

“MORA” product lines provide EverEx’s proprietary AI pose estimation model-powered musculoskeletal assessment and personalized rehabilitation treatment with remote therapeutic monitoring.

“MORA”产品线提供EverEx专有的AI姿势估计模型，支持肌肉骨骼评估和个性化康复治疗，并提供远程治疗监测。

Recently, the digital therapeutics (DTx) product ‘MORA Cure’ has completed the Investigational Device Exemption (IDE) process and got approval from the South Korean Ministry of Food and Drug Safety (MFDS) as the first DTx in the musculoskeletal field to proceed with a clinical trial specifically targeting patellofemoral pain syndrome.

最近，数字治疗（DTx）产品“MORA Cure”完成了研究设备豁免（IDE）程序，并获得了韩国食品和药物安全部（MFDS）的批准，成为肌肉骨骼领域第一个进行专门针对髌股疼痛综合征的临床试验的DTx。

This achievement underscores EverEx's commitment to advancing solutions for musculoskeletal disorders and represents a significant step forward in its efforts to introduce effective digital therapies to the market..

这一成就突显了EverEx致力于推进肌肉骨骼疾病的解决方案，并标志着其向市场引入有效数字疗法的努力向前迈出了重要一步。。

Moreover, EverEx has introduced AI-powered FDA Class 2 software medical device “EverEx Rehab” to the U.S. market, targeting musculoskeletal remote therapeutic monitoring (RTM). Its well-received presentation at the American Physical Therapy Association conference has sparked significant interest among healthcare professionals..

此外，EverEx已将人工智能驱动的FDA 2级软件医疗设备“EverEx Rehab”引入美国市场，针对肌肉骨骼远程治疗监测（RTM）。它在美国物理治疗协会会议上广受欢迎的演讲引发了医疗保健专业人士的极大兴趣。。

About EverEx

关于EverEx

Founded in August 2019 by orthopedic surgeon Dr. Chan Yoon, EverEx is a global digital healthcare startup focusing on musculoskeletal health. Driven by the goal to enhance digital rehabilitation solutions for musculoskeletal conditions, EverEx has assembled a multidisciplinary team of approximately 40 experts in orthopedics, rehabilitation medicine, psychiatry, and various technology fields.

EverEx由整形外科医生Chan Yoon博士于2019年8月成立，是一家专注于肌肉骨骼健康的全球数字医疗初创公司。在加强肌肉骨骼疾病数字康复解决方案目标的推动下，EverEx组建了一个由骨科、康复医学、精神病学和各种技术领域约40名专家组成的多学科团队。

Coming off a recent win at the CES 2024 Innovation Award, EverEx is poised for significant expansion in the U.S. market with EverEx Rehab. For more information, visit everex.health..

在最近赢得CES 2024创新奖后，EverEx准备通过EverEx Rehab在美国市场进行重大扩张。有关更多信息，请访问everex.health。。